Opportunity, I do not think a new CEO would get the stock noticed an better than what Dr. Moro is currently doing. Promoting OTC.BB stocks is very difficult. No analysts want to hang out their rep for the company and BioCurex is limited in funds to do much else. However, I would certainly get rid of Wittenberg and get a new CFO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.